Back to mobile site

Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Stronger Gross Margins Drive Q4 Upside EPS

February 25, 2011 8:30 AM EST Send to a Friend
Needham & Company reiterates a 'Buy' on Ceradyne (NASDAQ: CRDN), PT increased from $40 to $43.

Needham analyst says, "CRDN ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login